| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |